Deborah Morosini

4.5k citations
33 papers · 1.9k · 1 hit paper · h-index 18

Impact in

  • Oncology top 2%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Diagnosis and Treatment
    • Lung Cancer Research Studies
    • Cancer-related Molecular Pathways
  • Cancer Research top 5%
    • Cancer Genomics and Diagnostics

Papers in

Co-authors
Philip J. Stephens (14 shared papers)Jeffrey S. Ross (20 shared papers)Siraj M. Ali (18 shared papers)Vincent A. Miller (18 shared papers)Doron Lipson (16 shared papers)Roman Yelensky (16 shared papers)Gary A. Palmer (11 shared papers)Kai Wang (13 shared papers)
Journals
Journal of Clinical Oncology (7 papers)Cancer Research (6 papers)The Oncologist (4 papers)Journal of Clinical Pathology (2 papers)Cancer Discovery (2 papers)
Partner nations
United StatesIsrael

In The Last Decade

Deborah Morosini

30 papers receiving 1.9k citations

Deborah Morosini's Hit Papers

An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101 2015 · 302 citations
3020+3+7Years since publication100200300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2015 Cancer Discovery

Peers

Deborah Morosini
Comparison fields: 5 of 76
  • Oncology 1.1k
  • Cancer Research 449
  • Pathology and Forensic Medicine 379
  • Pulmonary and Respiratory Medicine 545
  • Oral Surgery 82
Replace So Young Kang with:
So Young Kang South Korea
Lorenza Pecciarini Italy
James Suh United States
Isabelle Soubeyran France
Jau‐Yu Liau Taiwan
Ettore Macrì Italy
Stefania Benini Italy
Esma Saâda-Bouzid France
Yoshiyuki Suehara Japan
Erminia Manfrin Italy
Deborah Morosini relative to So Young Kang South Korea So Young Kang's profile →
Citations per field
00.5×1.5×1.9×
So Young Kang · 1×
Citations per year

Countries citing papers authored by Deborah Morosini

Since Specialization
Citations

This map shows the geographic impact of Deborah Morosini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Morosini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Morosini more than expected).

Fields of papers citing papers by Deborah Morosini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Morosini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Morosini. The network helps show where Deborah Morosini may publish in the future.

Co-authors

The 25 scholars most cited alongside Deborah Morosini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deborah Morosini Line = papers co-authored together Deborah Morosini links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1
New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing
The Oncologist ·Jeffrey S. Ross, Kai Wang, Laurie M. Gay, Rami N. Al‐Rohil, Janne V. Rand, David Jones, Hwa J. Lee, Christine E. Sheehan, Geoff Otto, Gary A. Palmer, Roman Yelensky, Doron Lipson, Deborah Morosini, Matthew Hawryluk, Daniel V.T. Catenacci, Vincent A. Miller, Chaitanya Churi, Siraj M. Ali, Philip J. Stephens
2014341
2
An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
Cancer Discovery ·Robert C. Doebele, Lara E. Davis, Aria Vaishnavi, Anh T. Le, Adriana Estrada‐Bernal, Stephen B. Keysar, Antonio Jimeno, Marileila Varella‐Garcia, Dara L. Aisner, Yali Li, Philip J. Stephens, Deborah Morosini, Brian B. Tuch, Michele Fernandes, Nisha Nanda, Jennifer A. Low
Hit paper breakdown →		2015302
3
Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair
Cancer Research ·Meredith A. Morgan, Leslie A. Parsels, Lili Zhao, Joshua D. Parsels, Mary A. Davis, Maria Hassan, Sankari Arumugarajah, Linda Hylander-Gans, Deborah Morosini, Diane M. Simeone, Christine E. Canman, Daniel P. Normolle, Sonya Zabludoff, Jonathan Maybaum, Theodore S. Lawrence
2010249
4
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site
JAMA Oncology ·Jeffrey S. Ross, Kai Wang, Laurie M. Gay, Geoff Otto, Emily White, Kiel Iwanik, Gary A. Palmer, Roman Yelensky, Doron Lipson, Juliann Chmielecki, Rachel Erlich, Andrew Rankin, Siraj M. Ali, Julia A. Elvin, Deborah Morosini, Vincent A. Miller, Philip J. Stephens
2015164
5
Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480
Cancer Research ·Xin Hong, Andreas Herrmann, Karen L. Reckamp, Wang Zhang, Sumanta K. Pal, Michael Hedvat, Chunyan Zhang, Wei Liang, Anna Scuto, Shaobu Weng, Deborah Morosini, Zhu Cao, Michael Zinda, Robert A. Figlin, Dennis Huszar, Richard Jove, Hua Yu
201193
6
Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer
Journal of Clinical Pathology ·Jeffrey S. Ross, K Wang, Osama Elkadi, Ashley J. Tarasen, Llewelyn Foulke, Christine E. Sheehan, Geoff Otto, Gary A. Palmer, Roman Yelensky, Doron Lipson, Juliann Chmielecki, Siraj M. Ali, Julia A. Elvin, Deborah Morosini, V.A. Miller, Philip J. Stephens
201478
7
Oncogenic Alterations in ERBB2/HER2 Represent Potential Therapeutic Targets Across Tumors From Diverse Anatomic Sites of Origin
The Oncologist ·Juliann Chmielecki, Jeffrey S. Ross, Kai Wang, Garrett M. Frampton, Gary A. Palmer, Siraj M. Ali, Norma Alonzo Palma, Deborah Morosini, Vincent A. Miller, Roman Yelensky, Doron Lipson, Philip J. Stephens
201475
8
BRAF V600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF–MEK Combination Therapy
Cancer Discovery ·Samuel J. Klempner, Bruce Gershenhorn, Phu N. Tran, Thomas K. Lee, Mark G. Erlander, Kyle Gowen, Alexa B. Schrock, Deborah Morosini, Jeffrey S. Ross, Vincent A. Miller, Philip J. Stephens, Sai‐Hong Ignatius Ou, Siraj M. Ali
201674
9
Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition
Clinical Cancer Research ·Leslie A. Parsels, Yushen Qian, Daria M. Tanska, Marisa Gross, Lili Zhao, Maria Hassan, Sankari Arumugarajah, Joshua D. Parsels, Linda Hylander-Gans, Diane M. Simeone, Deborah Morosini, Jeffrey L. Brown, Sonya Zabludoff, Jonathan Maybaum, Theodore S. Lawrence, Meredith A. Morgan
201167
10
Prospective Comprehensive Genomic Profiling of Advanced Gastric Carcinoma Cases Reveals Frequent Clinically Relevant Genomic Alterations and New Routes for Targeted Therapies
The Oncologist ·Siraj M. Ali, Eric M. Sanford, Samuel J. Klempner, Douglas A. Rubinson, Kai Wang, Norma Alonzo Palma, Juliann Chmielecki, Roman Yelensky, Gary A. Palmer, Deborah Morosini, Doron Lipson, Daniel V.T. Catenacci, Fadi Braiteh, Rachel Erlich, Philip J. Stephens, Jeffrey S. Ross, Sai‐Hong Ignatius Ou, Vincent A. Miller
201565
11
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations
Breast Cancer Research and Treatment ·Jeffrey S. Ross, Siraj M. Ali, Kai Wang, Depinder Khaira, Norma Alonzo Palma, Juliann Chmielecki, Gary A. Palmer, Deborah Morosini, Julia A. Elvin, Sandra V. Fernandez, Vincent A. Miller, Philip J. Stephens, Massimo Cristofanilli
201561
12
Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations
The Oncologist ·Siraj M. Ali, Sumanta K. Pal, Kai Wang, Norma Alonzo Palma, Eric M. Sanford, Mark Bailey, Jie He, Julia A. Elvin, Juliann Chmielecki, Rachel M. Squillace, Edward Dow, Deborah Morosini, Jamie Buell, Roman Yelensky, Doron Lipson, Garrett M. Frampton, Peter M. Howley, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller
201561
13
Genomic Profiling of Advanced-Stage, Metaplastic Breast Carcinoma by Next-Generation Sequencing Reveals Frequent, Targetable Genomic Abnormalities and Potential New Treatment Options
Archives of Pathology & Laboratory Medicine ·Jeffrey S. Ross, Sunil Badve, Kai Wang, Christine E. Sheehan, Ann Boguniewicz, Geoff Otto, Roman Yelensky, Doron Lipson, Siraj M. Ali, Deborah Morosini, Juliann Chliemlecki, Julia A. Elvin, Vincent A. Miller, Philip J. Stephens
201555
14
Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies
Journal of Clinical Pathology ·Jeffrey S. Ross, K Wang, Janne V. Rand, Laurie M. Gay, Marco Presta, Christine E. Sheehan, Siraj M. Ali, Julia A. Elvin, Elaine LaBrecque, Christine N. Hiemstra, Jamie Buell, Geoffrey A. Otto, Roman Yelensky, Doron Lipson, Deborah Morosini, Juliann Chmielecki, V.A. Miller, Phil Stephens
201451
15
Vemurafenib Response in 2 Patients With Posttransplant Refractory BRAF V600E–Mutated Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia ·Jeff P. Sharman, Juliann Chmielecki, Deborah Morosini, Gary A. Palmer, Jeff Ross, P. J. Stephens, J. Stafl, V.A. Miller, Sonia Ali
201441
16
Durable Response to Crizotinib in a MET-Amplified, KRAS-Mutated Carcinoma of Unknown Primary
Case Reports in Oncology ·Norma Alonzo Palma, Siraj M. Ali, Jamie O'Connor, Deepa Dutta, Kai Wang, Salil Soman, Gary A. Palmer, Deborah Morosini, Jeffrey S. Ross, Doron Lipson, Phil Stephens, Mayur M. Patel, Vincent A. Miller, Nicholas Koutrelakos
201423
17
Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression
Oncotarget ·Chih-Min Tang, Tracy E. Lee, Sabriya A. Syed, Adam M. Burgoyne, Stephanie Y. Leonard, Fei Gao, Jonathan C. Chan, Eileen Shi, Juliann Chmielecki, Deborah Morosini, Kai Wang, Jeffrey S. Ross, Michael L. Kendrick, Michael R. Bardsley, Martina De Siena, Junhao Mao, Olivier Harismendy, Tamás Ördög, Jason K. Sicklick
201623
18
Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring anSTK11variant
Molecular Case Studies ·Christine A. Parachoniak, Andrew Rankin, Bernadette Gaffney, Ryan J. Hartmaier, Dan Spritz, Rachel Erlich, Vincent A. Miller, Deborah Morosini, Phil Stephens, Jeffrey S. Ross, John A. Keech, Juliann Chmielecki
201719
19
Identifying ALK rearrangements that are not detected by FISH with targeted next-generation sequencing of lung carcinoma.
Journal of Clinical Oncology ·Siraj M. Ali, Sai‐Hong Ignatius Ou, Jie He, Nir Peled, Juliann Chmielecki, Mary Pinder, Norma Alonzo Palma, Wallace Akerley, Kai Wang, Julian R. Molina, Jeffrey S. Ross, Roman Yelensky, Garrett M. Frampton, Lyudmila Bazhenova, Gary A. Palmer, Deborah Morosini, Doron Lipson, Phil Stephens, Ravi Salgia, Vincent A. Miller
201411
20
Abstract 1118: Activation of MET via diverse exon 14 skipping mutations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors
Cancer Research ·Garrett M. Frampton, Siraj M. Ali, Juliann Chmielecki, Mark R. Rosenzweig, Timothy Brennan, Zachary R. Chalmers, Julia A. Elvin, Alex Fichtenholtz, Kyle Gowan, Joel Greenbowe, Adrienne Johnson, Lily Khaira, Doron Lipson, Caitlin McMahon, Steven Roels, Roman Yelensky, Deborah Morosini, Philip Stephens, Vincent A. Miller
20158

About Deborah Morosini

Deborah Morosini is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Genomics and Diagnostics (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Diagnosis and Treatment (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Tumors and Oncological Cases (3 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (449 citations), Pathology and Forensic Medicine (379 citations), Pulmonary and Respiratory Medicine (545 citations) and Oral Surgery (82 citations). Deborah Morosini has collaborated with scholars based in United States and Israel. Frequent co-authors include Philip J. Stephens, Jeffrey S. Ross, Siraj M. Ali, Vincent A. Miller, Doron Lipson, Roman Yelensky, Gary A. Palmer, Kai Wang, Juliann Chmielecki and Geoff Otto. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Oncologist, Journal of Clinical Pathology and Cancer Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by So Young KangBreakdown of academic impact, for papers by Lorenza PecciariniBreakdown of academic impact, for papers by James SuhBreakdown of academic impact, for papers by Isabelle SoubeyranBreakdown of academic impact, for papers by Jau‐Yu LiauBreakdown of academic impact, for papers by Ettore MacrìBreakdown of academic impact, for papers by Stefania BeniniBreakdown of academic impact, for papers by Esma Saâda-BouzidBreakdown of academic impact, for papers by Yoshiyuki SueharaBreakdown of academic impact, for papers by Erminia Manfrin